How Participants Behave and Respond on Their Own After Completing a 2-year Intervention of Calorie Restriction
NCT ID: NCT00943215
Last Updated: 2016-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2009-07-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CALERIE Phase II Ancillary: Metabolic
NCT02695511
CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
NCT00427193
Clinical Study to Test the Effects of a Low-Carbohydrate Diet on Body Weight
NCT00351845
Effect of 24 h Severe Energy Restriction on Appetite Regulation and Ad-libitum Energy Intake
NCT02696772
CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
NCT00099151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Month 3 and Month 6 (Outpatient Visits)following procedures performed:
* Blood pressure, heart rate, temperature, Weight \& Waist Measurement
* Medication and medical history
* Blood draw (approximately ½ cup)
* DEXA and QuickScan
* Psychological assessment questionnaires reviewed for completeness
* Body Acceptability Morph Test (BAM)
* Review of 7-day food diary
Month 12 and Month 24 (Outpatient Visits) procedures performed:
* Collection of 4 urine samples
* Dosing with doubly labeled water (DLW)
* DEXA and QuickScan
* Eat breakfast and lunch
* Receive 7-day food diary
* Psychological assessment questionnaires
* Body Acceptability Morph Test (BAM)
Fourteen days after Month 12 and Month 24 (Overnight Inpatient Visits) following procedures performed:
* Collection of 2 urine samples
* Blood pressure, heart rate, temperature, Weight \& Waist Measurement
* Blood draw (approximately ½ cup)
* Medication and medical history
* Review of 7-day food diary
* Metabolic Chamber
* Resting Metabolic Rate (RMR)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric Ravussin
Princiapal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Ravussin, PhD
Role: PRINCIPAL_INVESTIGATOR
Pennington Biomedical Research Center
References
Explore related publications, articles, or registry entries linked to this study.
Marlatt KL, Redman LM, Burton JH, Martin CK, Ravussin E. Persistence of weight loss and acquired behaviors 2 y after stopping a 2-y calorie restriction intervention. Am J Clin Nutr. 2017 Apr;105(4):928-935. doi: 10.3945/ajcn.116.146837. Epub 2017 Mar 8.
Lam YY, Redman LM, Smith SR, Bray GA, Greenway FL, Johannsen D, Ravussin E. Determinants of sedentary 24-h energy expenditure: equations for energy prescription and adjustment in a respiratory chamber. Am J Clin Nutr. 2014 Apr;99(4):834-42. doi: 10.3945/ajcn.113.079566. Epub 2014 Feb 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH U01 AG20478
Identifier Type: OTHER
Identifier Source: secondary_id
PBRC 29012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.